Paul G Gottschalk

Summary

Publications

  1. ncbi Measuring parallelism, linearity, and relative potency in bioassay and immunoassay data
    Paul G Gottschalk
    Brendan Technologies, Inc, Carlsbad, CA 92008, USA
    J Biopharm Stat 15:437-63. 2005
  2. ncbi The five-parameter logistic: a characterization and comparison with the four-parameter logistic
    Paul G Gottschalk
    Brendan Technologies, Inc, 2236 Rutherford Road, Suite 107, Carlsbad, CA 92008, USA
    Anal Biochem 343:54-65. 2005
  3. ncbi Determining the error of dose estimates and minimum and maximum acceptable concentrations from assays with nonlinear dose-response curves
    Paul G Gottschalk
    Brendan Technologies, Inc, Carlsbad, CA 92008, USA
    Comput Methods Programs Biomed 80:204-15. 2005

Detail Information

Publications3

  1. ncbi Measuring parallelism, linearity, and relative potency in bioassay and immunoassay data
    Paul G Gottschalk
    Brendan Technologies, Inc, Carlsbad, CA 92008, USA
    J Biopharm Stat 15:437-63. 2005
    ..The effect of noise, as well as the importance of correct weighting on the parallelism metrics and the relative potency, is also studied...
  2. ncbi The five-parameter logistic: a characterization and comparison with the four-parameter logistic
    Paul G Gottschalk
    Brendan Technologies, Inc, 2236 Rutherford Road, Suite 107, Carlsbad, CA 92008, USA
    Anal Biochem 343:54-65. 2005
    ..The behavior of the 5PL curve and how it differs from the 4PL curve are discussed. Common experimental designs, which can lead to ill-conditioned regression problems, are also examined...
  3. ncbi Determining the error of dose estimates and minimum and maximum acceptable concentrations from assays with nonlinear dose-response curves
    Paul G Gottschalk
    Brendan Technologies, Inc, Carlsbad, CA 92008, USA
    Comput Methods Programs Biomed 80:204-15. 2005
    ....